What we do know:
MACC offerings released October 17
1st quarter CCUK EBITDA $0.35m
1st quarter GLAF EBITDA -$0.1m
2017 NPAT guidance = $20-$23m
1st quarter NPAT - $6.25m
So to meet stated guidance of $21.5m
2nd quarter - $5.1m
3rd quarter - $5.1m
4th quarter - $5.1m
My thoughts:
1.5c dividend x2 for FY17
2nd quarter NPAT - $6.00m
CCUK, GLAF and MACC all to be positive
Don't forget the governments proposed changes are flawed potentially in favour of Cash Converters:
This change will impact around 500,000 Cash Converters customers who access our short term Cash Advances (six-week loans). To address their need for credit and meet the new cap, these customers would now be required to take out 12-week loans, resulting in more monthly fees and a restriction of consumer choice.
What we do know: MACC offerings released October 17 1st quarter...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $138.0M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.5¢ | $3.136K | 13.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55402 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 50865 | 1 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| CCV (ASX) Chart |
